← All trials
NCT03235947
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 7, 2016
- Primary completion
- Nov 6, 2017
- Completion date
- Nov 6, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 82
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranLead sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOverall official - principal investigator
- Laboratorios Senosiain, S.A. de C.V.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.